Upgrade to SI Premium - Free Trial

UiPath Inc. (PATH) PT Lowered to $14 at Canaccord Genuity

March 13, 2025 6:52 AM
Canaccord Genuity analyst Kingsley Cran lowered the price target on UiPath Inc. (NYSE: PATH) to $14.00 (from $19.00) while maintaining a Buy rating.

Categories

Analyst PT Change

Next Articles